MUNICH – Biotechnology company Insempra has announced a strategic investment in synthetic biology company Solena in a bid to accelerate the development of “naturally superior” materials.
Solena, a spin-out from Imperial College London, develops synthetic proteins for high-performance clothing fibres which subsequently have a lesser impact on the environment than conventional textiles.
Jens Klein, founder and CEO of Insempra and CEO of Solena Materials, commented: “We are hugely excited by this investment in Solena, which will help to accelerate our market-first approach to develop superior, intrinsically sustainable ingredients.”
